MARKET

PBE

PBE

Invesco Dynamic Biotech & Genome ETF
NYSEARCA
67.18
+0.24
+0.36%
Closed 15:50 01/27 EST
OPEN
66.92
PREV CLOSE
66.94
HIGH
67.40
LOW
66.92
VOLUME
4.45K
TURNOVER
238.44K
52 WEEK HIGH
68.11
52 WEEK LOW
51.39
TOTAL ASSET
268.02M
YTD YIELD
18.24%
1D
5D
1M
3M
1Y
5Y
Healthy Outlook For Therapeutics
Seeking Alpha · 3d ago
More Volatility Ahead? Buckle Up With Defensive Equities
Seeking Alpha · 01/19 14:03
GNOM: Healthcare Dashboard For January
Seeking Alpha · 01/19 14:00
Healthcare Stocks: An Innovative Antidote For Volatile Times
Seeking Alpha · 01/12 05:30
Can Health Care Stocks Outperform Again In 2023?
Seeking Alpha · 01/11 23:09
Genomic & Biotech ETFs pop, including Cathie Wood’s ARKG
Biotechnology and genomics-based exchange traded funds like the Genomics &amp; Biotechnology ETF (NASDAQ:<a href="https://seekingalpha.com/symbol/GNOM?utm_medium=referral&utm_source=webull.com" title="Global X F...
Seekingalpha · 08/03/2022 16:07
Best Biotech ETFs for Q3 2022
Biotech companies use or modify biological processes to create new pharmaceuticals or therapies. Some of the most prominent biotech companies include Vertex Pharmaceuticals Inc. (VRTX) and Regeneron Pharmaceuticals Inc.
Investopedia · 06/04/2022 03:59
SEC Planned Crackdown on ‘Misleading’ Funds Goes Far Beyond ESG
Bloomberg · 05/26/2022 19:34
More
Profile
Fund Name
Invesco Dynamic Biotech & Genome ETF
Inception Date
2005-06-23
Benchmark
Dynamic Biotech&Genome Intellidex TR USD
Advisor Company
Invesco Capital Management LLC
Custodian
Bank of New York Mellon
Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Pratik Doshi